Detalhe da pesquisa
1.
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
Ther Adv Med Oncol
; 15: 17588359231156382, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025260
2.
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer.
Cancer Med
; 11(14): 2790-2800, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35307972
3.
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung.
Ther Adv Med Oncol
; 14: 17588359221133893, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324736
4.
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies.
JCO Precis Oncol
; 6: e2200072, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108261
5.
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival.
NPJ Precis Oncol
; 5(1): 33, 2021 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33911192
6.
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.
Nat Med
; 25(5): 751-758, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31011205
7.
Equal access to innovative therapies and precision cancer care.
Nat Rev Clin Oncol
; 13(6): 385-93, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000960
8.
[The CRA Foundation: The ambition of curing 2 cancers out of 3]. / Fondation ARC : l'ambition de guérir 2 cancers sur 3.
Bull Cancer
; 100(6): 543-5, 2013 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-23923517